• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受 TACE 治疗的 HCC 患者的症状群及症状干扰:中国的一项横断面研究。

Symptom clusters and symptom interference of HCC patients undergoing TACE: a cross-sectional study in China.

机构信息

Nursing School, Second Military Medical University, Room 314, No.800 Xiangyin Road, Yangpu District, Shanghai, 200433, People's Republic of China.

出版信息

Support Care Cancer. 2013 Feb;21(2):475-83. doi: 10.1007/s00520-012-1541-5. Epub 2012 Jul 20.

DOI:10.1007/s00520-012-1541-5
PMID:23010958
Abstract

OBJECTIVE

The aim of this study was to investigate the symptom and symptom clusters of patients with hepatocellular carcinoma (HCC) before and after transcatheter arterial chemoembolization (TACE), and to discuss the relationship between symptoms, symptom clusters, and symptom interference.

MATERIALS AND METHODS

Patients with HCC who received TACE were asked to rate their symptoms using the M. D. Anderson Symptom Inventory and the symptom checklist particularly for HCC. To determine the interrelationships among symptoms and identify the symptom clusters, a principal component analysis with varimax rotation was carried out on the symptom items. Spearman correlation analysis was done to assess the relationship between symptom clusters and symptom interference.

RESULTS

A total of 155 patients finished the whole procedure between November 2010 and May 2011. Before TACE, the five most severe symptoms, ranked in order, were fatigue (3.40 ± 2.26), distress (3.35 ± 2.60), sadness (3.01 ± 2.66), sleep disturbance (2.63 ± 2.57), and lack of appetite (2.26 ± 2.38). After TACE, fatigue (4.88 ± 2.31) was the most serious symptom, followed by sleep disturbance (4.80 ± 2.25), distress (4.59 ± 2.32), sadness (4.45 ± 2.16), lack of appetite (4.25 ± 2.51). Two symptom clusters were found before TACE: psychological symptom cluster and sickness symptom cluster. Two new symptom clusters were found after TACE: upper gastrointestinal symptom cluster and liver function impairment symptom cluster, with the two original symptom clusters remained relatively stable. The highest symptom interference items pre- and post-TACE were work and enjoyment of life, followed by mood. The symptoms of distress, sadness, fatigue, sleep disturbance, and lack of appetite were all significantly associated with the total interference (r = 0.443-0.615, p < 0.01 or p < 0.05). Symptom clusters were significantly correlated with the total symptom interference before and after TACE (r = 0.176-0.638, p < 0.01 or p < 0.05).

CONCLUSION

Psychological symptom cluster and sickness symptom cluster are common for HCC patients before and after TACE. Liver function impairment and upper gastrointestinal symptom clusters are directly related to TACE treatment. Both the symptoms and symptom clusters have significant interference on the daily life of HCC patients undergoing TACE. However, more work is needed to further clarify the symptom clusters associated with TACE and to test the effectiveness of TACE in easing symptoms and improving quality of life of HCC patients.

摘要

目的

本研究旨在探讨肝癌患者经肝动脉化疗栓塞术(TACE)前后的症状和症状群,并探讨症状、症状群与症状干扰之间的关系。

材料与方法

对 2010 年 11 月至 2011 年 5 月接受 TACE 的肝癌患者使用 M. D.安德森症状评估量表和肝癌症状检查表进行症状评估。采用主成分分析和最大方差旋转法对症状条目进行分析,以确定症状之间的相互关系并识别症状群。采用 Spearman 相关分析评估症状群与症状干扰之间的关系。

结果

共有 155 例患者完成了整个研究过程。TACE 前,按严重程度排序的前 5 个最严重症状依次为:乏力(3.40±2.26)、苦恼(3.35±2.60)、悲伤(3.01±2.66)、睡眠障碍(2.63±2.57)和食欲不振(2.26±2.38)。TACE 后,乏力(4.88±2.31)是最严重的症状,其次是睡眠障碍(4.80±2.25)、苦恼(4.59±2.32)、悲伤(4.45±2.16)和食欲不振(4.25±2.51)。TACE 前发现了两个症状群:心理症状群和疾病症状群。TACE 后发现了两个新的症状群:上消化道症状群和肝功能损害症状群,两个原始症状群相对稳定。TACE 前后症状干扰最高的项目是工作和生活享受,其次是情绪。苦恼、悲伤、乏力、睡眠障碍和食欲不振与总干扰均显著相关(r=0.443-0.615,p<0.01 或 p<0.05)。TACE 前后症状群与总症状干扰显著相关(r=0.176-0.638,p<0.01 或 p<0.05)。

结论

肝癌患者 TACE 前后常见心理症状群和疾病症状群。肝功能损害和上消化道症状群与 TACE 治疗直接相关。症状和症状群对接受 TACE 的肝癌患者的日常生活有显著干扰。然而,需要进一步研究 TACE 相关的症状群,并验证 TACE 缓解症状和提高肝癌患者生活质量的有效性。

相似文献

1
Symptom clusters and symptom interference of HCC patients undergoing TACE: a cross-sectional study in China.接受 TACE 治疗的 HCC 患者的症状群及症状干扰:中国的一项横断面研究。
Support Care Cancer. 2013 Feb;21(2):475-83. doi: 10.1007/s00520-012-1541-5. Epub 2012 Jul 20.
2
Comparison of differences and determinants between presence and absence of sleep disturbance in hepatocellular carcinoma patients.比较肝细胞癌患者存在和不存在睡眠障碍的差异及决定因素。
Cancer Nurs. 2011 Sep-Oct;34(5):354-60. doi: 10.1097/NCC.0b013e3182037bf3.
3
Clinical Characteristics of Transarterial Chemoembolization in Treatment of Primary Hepatocellular Carcinoma Complicated With Respiratory Distress Syndrome.经动脉化疗栓塞治疗原发性肝癌合并呼吸窘迫综合征的临床特点。
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820970673. doi: 10.1177/1533033820970673.
4
Symptom clusters and nutritional status in primary liver cancer patients receiving transcatheter arterial chemoembolization.原发性肝癌患者经导管动脉化疗栓塞术后的症状群与营养状况。
Nutr Hosp. 2024 Aug 29;41(4):815-823. doi: 10.20960/nh.04936.
5
[Identification and validation of symptom clusters in patients with hepatocellular carcinoma].[肝细胞癌患者症状群的识别与验证]
J Korean Acad Nurs. 2009 Oct;39(5):683-92. doi: 10.4040/jkan.2009.39.5.683.
6
Quality of life after radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma: comparison with transcatheter arterial chemoembolization alone.射频消融联合经动脉化疗栓塞治疗肝细胞癌后的生活质量:与单纯经动脉化疗栓塞的比较
Qual Life Res. 2007 Apr;16(3):389-97. doi: 10.1007/s11136-006-9133-9. Epub 2006 Nov 17.
7
Transcatheter arterial chemoembolization confers survival benefit in patients with a spontaneously ruptured hepatocellular carcinoma.经导管动脉化疗栓塞术为自发性破裂肝细胞癌患者带来生存获益。
Eur J Gastroenterol Hepatol. 2012 Jun;24(6):640-5. doi: 10.1097/MEG.0b013e3283524d32.
8
Symptom Clusters and Impact of Fatigue and Sleep Disturbance on Symptom Experiences of Hepatoma Patients in Taiwan.台湾肝癌患者的症状群以及疲劳和睡眠障碍对症状体验的影响
Cancer Nurs. 2017 Sep/Oct;40(5):403-411. doi: 10.1097/NCC.0000000000000417.
9
The safety and efficacy of balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma refractory to conventional transcatheter arterial chemoembolization.球囊阻塞经导管动脉化疗栓塞术治疗常规经导管动脉化疗栓塞术抵抗的肝细胞癌的安全性和有效性。
Eur Radiol. 2020 Oct;30(10):5650-5662. doi: 10.1007/s00330-020-06911-9. Epub 2020 May 15.
10
[Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].[不可切除的大型肝细胞癌(HCC)介入治疗的长期结果:与单纯经动脉化疗栓塞术(TACE)相比,经动脉化疗栓塞术(TACE)联合经皮乙醇注射(PEI)可显著提高生存率]
Rofo. 2004 Dec;176(12):1794-802. doi: 10.1055/s-2004-813669.

引用本文的文献

1
Health-related quality of life in Thai patients with hepatocellular carcinoma and its influencing factors: A cross-sectional study.泰国肝细胞癌患者的健康相关生活质量及其影响因素:一项横断面研究。
Belitung Nurs J. 2025 Aug 3;11(4):370-383. doi: 10.33546/bnj.3853. eCollection 2025.
2
The first validation of the Functional Assessment of Cancer Therapy Hepatobiliary (FACT-Hep) for evaluating health-related quality of life (HRQOL) in patients with advanced-stage intrahepatic cholangiocarcinoma (biliary tract cancer).用于评估晚期肝内胆管癌(胆管癌)患者健康相关生活质量(HRQOL)的癌症治疗功能评估肝胆版(FACT-Hep)的首次验证。
PLoS One. 2025 Apr 28;20(4):e0321618. doi: 10.1371/journal.pone.0321618. eCollection 2025.
3

本文引用的文献

1
Prospective evaluation of transcatheter arterial chemoembolization (TACE) with multiple anti-cancer drugs (epirubicin, cisplatin, mitomycin c, 5-fluorouracil) compared with TACE with epirubicin for treatment of hepatocellular carcinoma.多抗癌药物(表柔比星、顺铂、丝裂霉素 C、5-氟尿嘧啶)经导管动脉化疗栓塞(TACE)与 TACE 联合表柔比星治疗肝细胞癌的前瞻性评估。
Cardiovasc Intervent Radiol. 2012 Dec;35(6):1363-71. doi: 10.1007/s00270-012-0352-x. Epub 2012 Feb 23.
2
Comparison of transcatheter arterial chemoembolization and microsphere embolization for treatment of unresectable hepatocellular carcinoma: a meta-analysis.经导管动脉化疗栓塞与微球栓塞治疗不可切除肝细胞癌的比较:一项荟萃分析。
J Cancer Res Clin Oncol. 2012 Mar;138(3):455-62. doi: 10.1007/s00432-011-1117-7. Epub 2011 Dec 18.
3
Improving Health-Related Quality of Life in Hepatocellular Carcinoma Patients: Key Methodologies for Assessing Patient Reported Outcomes and Intervention Targets.
改善肝细胞癌患者与健康相关的生活质量:评估患者报告结局和干预靶点的关键方法
J Hepatocell Carcinoma. 2025 Mar 5;12:497-511. doi: 10.2147/JHC.S347929. eCollection 2025.
4
Effect of perceived stress on psychological distress in hepatocellular carcinoma patients undergoing TACE: the mediating role of experiential avoidance and the moderating role of trait mindfulness.感知压力对接受经动脉化疗栓塞术的肝细胞癌患者心理困扰的影响:经验性回避的中介作用和特质正念的调节作用。
BMC Cancer. 2025 Feb 13;25(1):254. doi: 10.1186/s12885-025-13679-y.
5
Associations of tumor-related psychiatric symptoms and healthy behaviors with dynamic quality of life after hepatocellular carcinoma hepatectomy.肝癌切除术患者肿瘤相关精神症状与健康行为对生活质量动态变化的影响。
Support Care Cancer. 2024 Aug 14;32(9):589. doi: 10.1007/s00520-024-08790-y.
6
Symptom clusters and network analysis of patients with intermediate and advanced liver cancer treated with targeted immunotherapy.针对中晚期肝癌患者进行靶向免疫治疗的症状群及网络分析。
Support Care Cancer. 2024 Aug 8;32(9):580. doi: 10.1007/s00520-024-08784-w.
7
Symptoms experienced after transcatheter arterial chemoembolization in patients with primary liver cancer: A network analysis.原发性肝癌患者经动脉化疗栓塞术后的症状:一项网络分析
Asia Pac J Oncol Nurs. 2023 Dec 9;11(3):100361. doi: 10.1016/j.apjon.2023.100361. eCollection 2024 Mar.
8
Symptoms and symptom clusters in patients with hepatocellular carcinoma and commonly used instruments: An integrated review.肝细胞癌患者的症状及症状群与常用工具:一项综合综述。
Int J Nurs Sci. 2023 Sep 21;11(1):66-75. doi: 10.1016/j.ijnss.2023.09.009. eCollection 2024 Jan.
9
Effect of music therapy on postembolization syndrome in Thai patients with hepatocellular carcinoma: A quasi-experimental crossover study.音乐疗法对泰国肝细胞癌患者栓塞后综合征的影响:一项半实验性交叉研究。
Belitung Nurs J. 2022 Oct 21;8(5):396-404. doi: 10.33546/bnj.2210. eCollection 2022.
10
A comprehensive discharge planning program on fatigue and functional status of patients with hepatocellular carcinoma undergoing transarterial chemoembolization: A randomized clinical controlled trial.一项关于经动脉化疗栓塞术治疗的肝细胞癌患者疲劳和功能状态的综合出院计划项目:一项随机临床对照试验。
Belitung Nurs J. 2022 Aug 18;8(4):287-295. doi: 10.33546/bnj.2140. eCollection 2022.
Meta-analysis: traditional Chinese medicine for improving immune response in patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization.Meta 分析:经导管动脉化疗栓塞术治疗后不可切除的肝细胞癌患者的中药改善免疫反应。
Explore (NY). 2011 Jan-Feb;7(1):37-43. doi: 10.1016/j.explore.2010.10.002.
4
Current strategy for staging and treatment: the BCLC update and future prospects.当前的分期和治疗策略:BCLC 更新及未来展望。
Semin Liver Dis. 2010 Feb;30(1):61-74. doi: 10.1055/s-0030-1247133. Epub 2010 Feb 19.
5
Symptom clusters and quality of life in Korean patients with hepatocellular carcinoma.肝细胞癌韩国患者的症状群与生活质量。
Cancer Nurs. 2010 Jan-Feb;33(1):3-10. doi: 10.1097/NCC.0b013e3181b4367e.
6
A review of the prevalence and impact of multiple symptoms in oncology patients.肿瘤患者多种症状的患病率及影响综述。
J Pain Symptom Manage. 2009 Apr;37(4):715-36. doi: 10.1016/j.jpainsymman.2008.04.018. Epub 2008 Nov 20.
7
Treatment-related symptom clusters in breast cancer: a secondary analysis.乳腺癌中与治疗相关的症状群:一项二次分析
J Pain Symptom Manage. 2008 Nov;36(5):468-79. doi: 10.1016/j.jpainsymman.2007.11.011. Epub 2008 Aug 20.
8
Design and endpoints of clinical trials in hepatocellular carcinoma.肝细胞癌临床试验的设计与终点
J Natl Cancer Inst. 2008 May 21;100(10):698-711. doi: 10.1093/jnci/djn134. Epub 2008 May 13.
9
Efficacy of transcatheter embolization/chemoembolization (TAE/TACE) for the treatment of single hepatocellular carcinoma.经导管栓塞术/化疗栓塞术(TAE/TACE)治疗单发性肝细胞癌的疗效
World J Gastroenterol. 2007 Jun 7;13(21):2952-5. doi: 10.3748/wjg.v13.i21.2952.
10
The concept of symptom cluster.症状群的概念。
Semin Oncol Nurs. 2007 May;23(2):89-98. doi: 10.1016/j.soncn.2007.01.009.